PharmaCielo Statistics
Total Valuation
PharmaCielo has a market cap or net worth of CAD 8.46 million. The enterprise value is 28.84 million.
| Market Cap | 8.46M | 
| Enterprise Value | 28.84M | 
Important Dates
The next estimated earnings date is Monday, December 1, 2025.
| Earnings Date | Dec 1, 2025 | 
| Ex-Dividend Date | n/a | 
Share Statistics
PharmaCielo has 187.98 million shares outstanding. The number of shares has increased by 6.57% in one year.
| Current Share Class | 187.98M | 
| Shares Outstanding | 187.98M | 
| Shares Change (YoY) | +6.57% | 
| Shares Change (QoQ) | +8.17% | 
| Owned by Insiders (%) | 8.56% | 
| Owned by Institutions (%) | 0.18% | 
| Float | 171.90M | 
Valuation Ratios
| PE Ratio | n/a | 
| Forward PE | n/a | 
| PS Ratio | 3.12 | 
| PB Ratio | -0.77 | 
| P/TBV Ratio | n/a | 
| P/FCF Ratio | n/a | 
| P/OCF Ratio | 8.17 | 
| PEG Ratio | n/a | 
Enterprise Valuation
| EV / Earnings | -3.69 | 
| EV / Sales | 10.63 | 
| EV / EBITDA | n/a | 
| EV / EBIT | n/a | 
| EV / FCF | n/a | 
Financial Position
The company has a current ratio of 0.09
| Current Ratio | 0.09 | 
| Quick Ratio | 0.03 | 
| Debt / Equity | n/a | 
| Debt / EBITDA | n/a | 
| Debt / FCF | n/a | 
| Interest Coverage | -1.28 | 
Financial Efficiency
| Return on Equity (ROE) | n/a | 
| Return on Assets (ROA) | n/a | 
| Return on Invested Capital (ROIC) | n/a | 
| Return on Capital Employed (ROCE) | 34.42% | 
| Revenue Per Employee | n/a | 
| Profits Per Employee | n/a | 
| Employee Count | n/a | 
| Asset Turnover | n/a | 
| Inventory Turnover | n/a | 
Taxes
| Income Tax | n/a | 
| Effective Tax Rate | n/a | 
Stock Price Statistics
The stock price has decreased by -59.09% in the last 52 weeks. The beta is 1.65, so PharmaCielo's price volatility has been higher than the market average.
| Beta (5Y) | 1.65 | 
| 52-Week Price Change | -59.09% | 
| 50-Day Moving Average | 0.05 | 
| 200-Day Moving Average | 0.07 | 
| Relative Strength Index (RSI) | 42.31 | 
| Average Volume (20 Days) | 3,731 | 
Short Selling Information
| Short Interest | n/a | 
| Short Previous Month | n/a | 
| Short % of Shares Out | n/a | 
| Short % of Float | n/a | 
| Short Ratio (days to cover) | n/a | 
Income Statement
In the last 12 months, PharmaCielo had revenue of CAD 2.71 million and -7.82 million in losses. Loss per share was -0.04.
| Revenue | 2.71M | 
| Gross Profit | 38,173 | 
| Operating Income | -3.79M | 
| Pretax Income | -7.82M | 
| Net Income | -7.82M | 
| EBITDA | -2.80M | 
| EBIT | -3.79M | 
| Loss Per Share | -0.04 | 
Balance Sheet
The company has 6,541 in cash and 20.80 million in debt, giving a net cash position of -20.80 million or -0.11 per share.
| Cash & Cash Equivalents | 6,541 | 
| Total Debt | 20.80M | 
| Net Cash | -20.80M | 
| Net Cash Per Share | -0.11 | 
| Equity (Book Value) | -11.02M | 
| Book Value Per Share | -0.06 | 
| Working Capital | -26.53M | 
Cash Flow
| Operating Cash Flow | 1.04M | 
| Capital Expenditures | n/a | 
| Free Cash Flow | n/a | 
| FCF Per Share | n/a | 
Margins
Gross margin is 1.41%, with operating and profit margins of -139.90% and -288.39%.
| Gross Margin | 1.41% | 
| Operating Margin | -139.90% | 
| Pretax Margin | -288.39% | 
| Profit Margin | -288.39% | 
| EBITDA Margin | -103.40% | 
| EBIT Margin | -139.90% | 
| FCF Margin | n/a | 
Dividends & Yields
PharmaCielo does not appear to pay any dividends at this time.
| Dividend Per Share | n/a | 
| Dividend Yield | n/a | 
| Dividend Growth (YoY) | n/a | 
| Years of Dividend Growth | n/a | 
| Payout Ratio | n/a | 
| Buyback Yield | -6.57% | 
| Shareholder Yield | -6.57% | 
| Earnings Yield | -92.46% | 
| FCF Yield | n/a | 
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a | 
| Lynch Upside | n/a | 
| Graham Number | n/a | 
| Graham Upside | n/a | 
Stock Splits
The last stock split was on January 18, 2019. It was a reverse split with a ratio of 0.083752.
| Last Split Date | Jan 18, 2019 | 
| Split Type | Reverse | 
| Split Ratio | 0.083752 | 
Scores
PharmaCielo has an Altman Z-Score of -18.32 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -18.32 | 
| Piotroski F-Score | 3 |